Sasha Grimm

Company: ELEGEN

Job title: Head of Product Management

Seminars:

Accelerating & De-risking the Path to Clinical Drug Development with the Cell-Free Synthesis of DNA 5:00 pm

Unlock greater speed and sequence diversity for screening by eliminating the time spent cloning plasmid DNA More economically scale DNA synthesis for personalized therapy De-risk clinical scale-up earlier in the development processRead more

day: Day One